BSE · 507486
Caprolactam Chemicals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹7 Cr with net profit ₹-1 Cr — a -10.5% net margin, versus 2.77% the period before.
Shareholding
As of 2026-06-30
- Promoter54.5%
- Public45.5%
7,992 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.13× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — LT-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #129 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 67.35 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,362 Cr | 93.51 | 26.02 | 26.72% | 17.05% |
| SRF Ltd. | ₹77,213 Cr | 34.46 | 5.5 | 13.07% | 13.01% |
| Linde India Limited | ₹56,603 Cr | 103.24 | 13.27 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹48,279 Cr | 443.04 | 6.19 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹44,101 Cr | 99.27 | 3.95 | 11.1% | 5.58% |
| Himadri Speciality Chem Limited | ₹38,370 Cr | 191.08 | 8.15 | 15.96% | 16.12% |
| Navin Fluorine International Ltd. | ₹37,898 Cr | 58.47 | 9.53 | 16.69% | 20.02% |
| Deepak Nitrite Ltd. | ₹22,422 Cr | 102.04 | 3.84 | 9.43% | 6.98% |
| Atul Ltd. | ₹20,029 Cr | 95.31 | 3.22 | 9.31% | 8.93% |
| Caprolactam Chemicals Ltd.(this company) | ₹21 Cr | 11.92 | 3.19 | 26.76% | 16.78% |
AI analysis
AI-generated · google/gemini-2.5-flashCaprolactam Chemicals Ltd. is listed on the Indian markets with a market capitalization of Rs 23 Cr. The company reported a revenue of Rs 6.75 Cr and an EPS of Rs 3.83. It has a PE ratio of 13.01 and a book value of Rs 14.3. The latest reported profit margin is 16.78%.
Positives
- +The Return on Equity (ROE) is 26.76%, indicating efficient use of shareholder funds.
- +The Return on Capital Employed (ROCE) is 18.25%.
Negatives
- −The company's annual revenue declined from Rs 7.14 Cr in Mar 2024 to Rs 6.75 Cr in Mar 2025.
- −The net profit turned negative in Mar 2025, reporting a loss of Rs 0.71 Cr.
- −The debt-to-equity ratio at 1.41 is relatively high.
- −The company's quarterly results for Dec 2024 and Mar 2025 showed negative net profit (-Rs 0.03 Cr and -Rs 0.45 Cr respectively).
- −The company is currently under LT-ASM, specifically ASM 1 surveillance.
Financial performance
Caprolactam Chemicals Ltd.'s annual revenue has fluctuated over the past few years. Revenue was Rs 6.40 Cr in Mar 2021, decreasing to Rs 2.47 Cr in Mar 2022, before rising to Rs 9.86 Cr in Mar 2023. Revenue then declined to Rs 7.14 Cr in Mar 2024 and further to Rs 6.75 Cr in Mar 2025. Net profit also varied, with Rs 0.65 Cr in Mar 2021, a loss of Rs 1.28 Cr in Mar 2022, a profit of Rs 2.55 Cr in Mar 2023, and a profit of Rs 0.20 Cr in Mar 2024, followed by a loss of Rs 0.71 Cr in Mar 2025.
Profitability & returns
The company's profit margin stands at 16.78%. Return on equity (ROE) is 26.76% and return on capital employed (ROCE) is 18.25%. Looking at annual EPS, it was Rs 1.41 in Mar 2021, fell to Rs -2.79 in Mar 2022, then increased to Rs 5.54 in Mar 2023. Subsequently, it decreased to Rs 0.43 in Mar 2024 and further to Rs -1.54 in Mar 2025.
Balance sheet
Caprolactam Chemicals Ltd. has a debt-to-equity ratio of 1.41. The book value per share is Rs 14.3. There are no reported pledges by the promoter group.
Ownership & pledges
As of June 30, 2026, the promoter holding in Caprolactam Chemicals Ltd. is 54.50%, while public shareholding is 45.50%. No shares are held by DIIs or FIIs. The number of shareholders is 7,992. There have been no reported pledges by the promoter group.
Regulatory & surveillance
The company is currently under LT-ASM, specifically ASM 1 surveillance.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Caprolactam Chemicals Ltd.share price & fundamentals